Volume | 8,720 |
|
|||||
News | - | ||||||
Day High | 2.2999 | Low High |
|||||
Day Low | 2.20 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.23 | 2.20 | 2.2999 | 2.22 | 2.30 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
172 | 8,720 | $ 2.24 | $ 19,501 | - | 0.80 - 12.68 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:49:17 | 1 | $ 2.29 | USD |
Incannex Healthcare Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Incannex Healthcare News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IXHL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.40 | 2.48 | 2.13 | 2.30 | 14,124 | -0.18 | -7.50% |
1 Month | 3.52 | 3.60 | 2.13 | 2.88 | 19,338 | -1.30 | -36.93% |
3 Months | 3.23 | 8.4697 | 2.13 | 5.72 | 339,046 | -1.01 | -31.27% |
6 Months | 0.86 | 12.68 | 0.80 | 5.85 | 195,851 | 1.36 | 158.14% |
1 Year | 2.24 | 12.68 | 0.80 | 4.88 | 130,633 | -0.02 | -0.89% |
3 Years | 11.00 | 90.00 | 0.80 | 7.24 | 90,772 | -8.78 | -79.82% |
5 Years | 11.00 | 90.00 | 0.80 | 7.24 | 90,772 | -8.78 | -79.82% |
Incannex Healthcare Description
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. |